| Dr Douglas R Mcdonald, MD, PHD | |
|
300 Longwood Ave, Fegan 6, Boston, MA 02115-5724 | |
| (617) 355-6117 | |
| (617) 730-0528 |
| Full Name | Dr Douglas R Mcdonald |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 25 Years |
| Location | 300 Longwood Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558447482 | NPI | - | NPPES |
| 2093481 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 213635 (Massachusetts) | Primary |
| 208000000X | Pediatrics | 213635 (Massachusetts) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Children's Hospital Pediatric Associates, Inc | 3476541830 | 246 |
News Archive
Novocure announced today that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted (7 yes; 3 no; 2 abstain) that for patients with supra-tentorial glioblastoma multiforme (GBM) tumors that recur after maximal surgical and radiation treatments, there is reasonable assurance that the benefits of the NovoTTF-100A System (NovoTTF) outweigh its risks when administered as a monotherapy in place of standard medical therapy.
The WHO's decision Thursday to declare H1N1 (swine) flu a pandemic will "speed the production of a vaccine against the new virus," however scientists continue to caution that "it will be fall at the earliest before the first doses are available," the Los Angeles Times reports.
Four sick cows ever discovered in the U.S., the one announced Tuesday being the first since 2006, and no human version of the illness linked to eating U.S. beef, is not enough to worry about. "From simply a public health issue, I put it very, very low," Cornell University food safety expert Martin Wiedmann said of the level of concern about mad cow disease. Maintaining confidence in exports fuels the nation's monitoring of the beef supply as much as continuing safety concerns, he said.
Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and GMP manufacture of monoclonal antibodies, fusion proteins and other therapeutic protein products, and Iconic Therapeutics, a company focused on the development of treatments for wet adult macular degeneration (wet AMD) and other ophthalmic diseases, today announced the completion of the manufacture of the first GMP lot of hI-con1(TM) recombinant Fc-Factor VII fusion protein.
› Verified 3 days ago
| Entity Name | Children's Hospital Pediatric Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306664 PECOS PAC ID: 3476541830 Enrollment ID: O20040504000964 |
News Archive
Novocure announced today that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted (7 yes; 3 no; 2 abstain) that for patients with supra-tentorial glioblastoma multiforme (GBM) tumors that recur after maximal surgical and radiation treatments, there is reasonable assurance that the benefits of the NovoTTF-100A System (NovoTTF) outweigh its risks when administered as a monotherapy in place of standard medical therapy.
The WHO's decision Thursday to declare H1N1 (swine) flu a pandemic will "speed the production of a vaccine against the new virus," however scientists continue to caution that "it will be fall at the earliest before the first doses are available," the Los Angeles Times reports.
Four sick cows ever discovered in the U.S., the one announced Tuesday being the first since 2006, and no human version of the illness linked to eating U.S. beef, is not enough to worry about. "From simply a public health issue, I put it very, very low," Cornell University food safety expert Martin Wiedmann said of the level of concern about mad cow disease. Maintaining confidence in exports fuels the nation's monitoring of the beef supply as much as continuing safety concerns, he said.
Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and GMP manufacture of monoclonal antibodies, fusion proteins and other therapeutic protein products, and Iconic Therapeutics, a company focused on the development of treatments for wet adult macular degeneration (wet AMD) and other ophthalmic diseases, today announced the completion of the manufacture of the first GMP lot of hI-con1(TM) recombinant Fc-Factor VII fusion protein.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas R Mcdonald, MD, PHD 300 Longwood Ave, Fegan 6, Boston, MA 02115-5724 Ph: (617) 355-6117 | Dr Douglas R Mcdonald, MD, PHD 300 Longwood Ave, Fegan 6, Boston, MA 02115-5724 Ph: (617) 355-6117 |
News Archive
Novocure announced today that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted (7 yes; 3 no; 2 abstain) that for patients with supra-tentorial glioblastoma multiforme (GBM) tumors that recur after maximal surgical and radiation treatments, there is reasonable assurance that the benefits of the NovoTTF-100A System (NovoTTF) outweigh its risks when administered as a monotherapy in place of standard medical therapy.
The WHO's decision Thursday to declare H1N1 (swine) flu a pandemic will "speed the production of a vaccine against the new virus," however scientists continue to caution that "it will be fall at the earliest before the first doses are available," the Los Angeles Times reports.
Four sick cows ever discovered in the U.S., the one announced Tuesday being the first since 2006, and no human version of the illness linked to eating U.S. beef, is not enough to worry about. "From simply a public health issue, I put it very, very low," Cornell University food safety expert Martin Wiedmann said of the level of concern about mad cow disease. Maintaining confidence in exports fuels the nation's monitoring of the beef supply as much as continuing safety concerns, he said.
Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and GMP manufacture of monoclonal antibodies, fusion proteins and other therapeutic protein products, and Iconic Therapeutics, a company focused on the development of treatments for wet adult macular degeneration (wet AMD) and other ophthalmic diseases, today announced the completion of the manufacture of the first GMP lot of hI-con1(TM) recombinant Fc-Factor VII fusion protein.
› Verified 3 days ago
Dr. David H. Sachs, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: Bldg. 149-9019, 13th Street, Boston, MA 02466 Phone: 617-726-4065 Fax: 617-726-4067 | |
Dr. Anne Esther Goldfeld, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 800 Huntington Ave, Boston, MA 02115 Phone: 617-278-3351 Fax: 617-278-3454 | |
Dr. Sachin Niranjan Baxi, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Fegan 6, Boston, MA 02115 Phone: 617-919-2489 Fax: 617-730-0310 | |
Dr. Richard Arthur Moscicki, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 15 Parkman St, Allergy Associates Wac 626, Boston, MA 02114 Phone: 617-726-3764 Fax: 617-252-7694 | |
Abduarahmn Almutairi, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6117 | |
John L Ohman, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 750 Washington St, Nemc Box 30, Boston, MA 02111 Phone: 617-636-5000 Fax: 617-636-4843 | |
Dr. Paul J. Maglione, MD, PHD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany St, Shapiro 9 Suite B, Boston, MA 02118 Phone: 617-638-7480 |